Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cube Biotech Acquires IBA Lifesciences | Contract Pharma
Breaking News

Cube Biotech Acquires IBA Lifesciences

Combines Cube Biotech’s protein technologies with IBA's high-performance research tools for protein isolation and analysis.

Cube Biotech and IBA Lifesciences, two innovators in the biotechnology industry, have merged to create a unified entity dedicated to advancing research and production capabilities for the life science industry.

The combined company will leverage its complementary strengths to deliver solutions in protein purification and stabilization and to enable research in the field of challenging drug targets.

By combining Cube Biotech’s expertise in protein technologies with IBA Lifesciences strength in high-performance research tools for protein isolation and analysis, the new entity aims to address the evolving needs of researchers and industry professionals worldwide.

Didier Dargent, CEO of Cube Biotech, stated, “This acquisition marks an exciting new chapter for both companies. Together, we will harness our collective expertise to push the boundaries of what’s possible in the life sciences and enable researchers to make groundbreaking discoveries.”

Mike Rothe, CEO of IBA Lifesciences, added, “The fusion of our technologies and talents creates an outstanding foundation for innovation. Our combined efforts will benefit our customers and strengthen our position as leaders in the biotechnology market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters